1. Dorfman LE, Floriani MA, Oliveira TMRDR, Cunegatto B, Rosa RFM, Zen PRG. The role of cytogenetics and molecular biology in the diagnosis, treatment and monitoring of patients with chronic myeloid leukemia. J Bras Patol E Med Lab. 2018;54(2):83–91.
2. Chereda B, Melo JV. Natural course and biology of CML. Ann Hematol. 2015;94(S2):107–21.
3. Pasternak G, Hochhaus A, Schultheis B, Hehlmann R. Chronic myelogenous leukemia: molecular and cellular aspects. J Cancer Res Clin Oncol. 1998;124(12):643–60.
4. Deininger MW, Shah NP, Altman JK, Berman E, Bhatia R, Bhatnagar B, et al. Chronic Myeloid Leukemia, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2020;18(10):1385–415.
5. Rohrbacher, M., Hasford, J. (2018). Epidemiology and etiology of chronic myeloid leukemia. In: Wiernik, P., Dutcher, J., Gertz, M. (eds) Neoplastic diseases of the blood. Springer, Cham.